FDA Final Guidance on Digital Clinical Trial Protocols
AI-generated summary for informational purposes only. Not legal advice. See the original source for the authoritative text.
This guidance sets a common digital format for clinical trial protocols used in drug development. It gives sponsors a standardized protocol template, shared terminology, and technical data fields so trial information can be created, reviewed, and exchanged more consistently across countries. Pharmaceutical companies, clinical research organizations, investigators, ethics bodies, and regulators are the main groups affected. Teams running clinical trials should review the template and technical specification and consider aligning protocol drafting and submission systems with the new ICH M11 CeSHarP standard.
AI-generated summary. May contain errors. Refer to official sources for legal decisions.
Key Changes
- Finalizes FDA guidance on the ICH M11 CeSHarP digital clinical trial protocol standard
- Introduces a standardized protocol template with common structure, headers, and text elements
- Provides technical specifications with harmonized terminology and data fields for electronic exchange